After years of litigation and a series of legal decisions that never really gave either side any clear advantage, the battle over testosterone therapy and the methods used to market it may finally be coming to a close.
Of the nearly 7,000 lawsuits filed by men claiming that their use of testosterone therapy led to dangerous complications including heart attacks, strokes, and blood clots, more than ...
continue reading...The same judge who previously overturned a $150 million AndroGel verdict has reversed a second verdict in the litigation worth over $140 million.
The case was brought by Tennessee resident Jeffrey Konrad. Konrad alleges that his two-month period of using AbbVie’s AndroGel testosterone replacement product caused him to have a heart attack in 2010. A Chicago jury agreed and awarded him $140,000 in compensatory damages and $140 million punitively in response ...
continue reading...When an AndroGel lawsuit brought against pharmaceutical manufacturer AbbVie resulted in a $150 million award for the Oregon resident who filed it, the legal world took notice. The award was unique not only for the amount, but also in the way the amount was distributed.
A Chicago jury awarded plaintiff Jesse Mitchell nothing in compensation for the injuries or medical costs he incurred after a heart attack he attributed ...
continue reading...An Arizona man was unsuccessful in his attempt to find AndroGel manufacturer AbbVie responsible for a pulmonary embolism he suffered two months after starting testosterone replacement therapy. The lawsuit, filed in 2014 and decided just recently, claimed that AbbVie misled the public by focusing most of its television advertising on off-label uses for the drug.
Testosterone therapy and replacement commercials have taken ...
continue reading...Testim maker Endo International’s Auxilium unit emerged victorious in the first trial over whether its testosterone therapy drug caused a heart attack in a patient.
The Tennessee plaintiff had been prescribed Testim for what he described as chronic fatigue and had been applying the testosterone gel to himself for over 6 months. In July 2014, he suffered a heart attack and was subsequently hospitalized twice. His recovery since ...
continue reading...Yet again, a jury sent AbbVie, maker of the popular prescription testosterone drug Androgel, a loud and clear message. A federal jury in Chicago found that AbbVie misrepresented the dangers of using Androgel. And to make sure the drugmaker got their message, it also reached a verdict in excess of $140 million.
This most recent trial is the second bellwether case to be tried in the federal testosterone replacement ...
continue reading...
